These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 29866706)
1. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke. Agarwal S; Koch G; Hillis AE; Huynh W; Ward NS; Vucic S; Kiernan MC J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):47-57. PubMed ID: 29866706 [TBL] [Abstract][Full Text] [Related]
2. Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease. Vucic S; Kiernan MC Neurotherapeutics; 2017 Jan; 14(1):91-106. PubMed ID: 27830492 [TBL] [Abstract][Full Text] [Related]
3. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Vucic S; Stanley Chen KH; Kiernan MC; Hallett M; Benninger DH; Di Lazzaro V; Rossini PM; Benussi A; Berardelli A; Currà A; Krieg SM; Lefaucheur JP; Long Lo Y; Macdonell RA; Massimini M; Rosanova M; Picht T; Stinear CM; Paulus W; Ugawa Y; Ziemann U; Chen R Clin Neurophysiol; 2023 Jun; 150():131-175. PubMed ID: 37068329 [TBL] [Abstract][Full Text] [Related]
4. Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis. McMackin R; Muthuraman M; Groppa S; Babiloni C; Taylor JP; Kiernan MC; Nasseroleslami B; Hardiman O J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1011-1020. PubMed ID: 30760643 [TBL] [Abstract][Full Text] [Related]
5. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology. Vucic S; Kiernan MC Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924 [TBL] [Abstract][Full Text] [Related]
6. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS. Vucic S; Pavey N; Haidar M; Turner BJ; Kiernan MC Neurosci Lett; 2021 Aug; 759():136039. PubMed ID: 34118310 [TBL] [Abstract][Full Text] [Related]
7. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia. Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904 [TBL] [Abstract][Full Text] [Related]
8. Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis. Timmins HC; Vucic S; Kiernan MC Curr Opin Neurol; 2023 Aug; 36(4):353-359. PubMed ID: 37387467 [TBL] [Abstract][Full Text] [Related]
9. Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability. Pennisi G; Ferri R; Lanza G; Cantone M; Pennisi M; Puglisi V; Malaguarnera G; Bella R J Neural Transm (Vienna); 2011 Apr; 118(4):587-98. PubMed ID: 21207079 [TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. van den Bos MAJ; Geevasinga N; Higashihara M; Menon P; Vucic S Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185581 [TBL] [Abstract][Full Text] [Related]
11. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Ni Z; Chen R Transl Neurodegener; 2015; 4():22. PubMed ID: 26579223 [TBL] [Abstract][Full Text] [Related]
12. Cortical hyperexcitability and plasticity in Alzheimer's disease: developments in understanding and management. van den Bos MAJ; Menon P; Vucic S Expert Rev Neurother; 2022; 22(11-12):981-993. PubMed ID: 36683586 [TBL] [Abstract][Full Text] [Related]
14. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Benussi A; Di Lorenzo F; Dell'Era V; Cosseddu M; Alberici A; Caratozzolo S; Cotelli MS; Micheli A; Rozzini L; Depari A; Flammini A; Ponzo V; Martorana A; Caltagirone C; Padovani A; Koch G; Borroni B Neurology; 2017 Aug; 89(7):665-672. PubMed ID: 28747446 [TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease. Nardone R; Tezzon F; Höller Y; Golaszewski S; Trinka E; Brigo F Acta Neurol Scand; 2014 Jun; 129(6):351-66. PubMed ID: 24506061 [TBL] [Abstract][Full Text] [Related]
16. [Transcranial magnetic stimulation: physiology and applications]. Arányi Z Ideggyogy Sz; 2005 Nov; 58(11-12):417-24. PubMed ID: 16491566 [TBL] [Abstract][Full Text] [Related]
17. Transcranial magnetic stimulation of degenerating brain: a comparison of normal aging, Alzheimer's, Parkinson's and Huntington's disease. Ljubisavljevic MR; Ismail FY; Filipovic S Curr Alzheimer Res; 2013 Jul; 10(6):578-96. PubMed ID: 23627752 [TBL] [Abstract][Full Text] [Related]
18. On the Use of TMS to Investigate the Pathophysiology of Neurodegenerative Diseases. Rawji V; Latorre A; Sharma N; Rothwell JC; Rocchi L Front Neurol; 2020; 11():584664. PubMed ID: 33224098 [TBL] [Abstract][Full Text] [Related]